Symmetry Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,581
Closed -$322K – 321
2024
Q2
$322K Hold
1,581
– – 0.02% 392
2024
Q1
$345K Hold
1,581
– – 0.03% 385
2023
Q4
$359K Sell
1,581
-694
-31% -$146K 0.02% 349
2023
Q3
$457K Sell
2,275
-373
-14% -$78.7K 0.02% 327
2023
Q2
$549K Hold
2,648
– – 0.03% 307
2023
Q1
$522K Hold
2,648
– – 0.03% 312
2022
Q4
$536K Hold
2,648
– – 0.03% 306
2022
Q3
$466K Hold
2,648
– – 0.03% 321
2022
Q2
$533K Hold
2,648
– – 0.04% 300
2022
Q1
$600K Sell
2,648
-483
-15% -$114K 0.04% 315
2021
Q4
$845K Buy
3,131
+258
+9% +$63.9K 0.05% 250
2021
Q3
$681K Hold
2,873
– – 0.04% 314
2021
Q2
$681K Hold
2,873
– – 0.05% 323
2021
Q1
$629K Hold
2,873
– – 0.05% 323
2020
Q4
$502K Sell
2,873
-1,312
-31% -$227K 0.04% 370
2020
Q3
$677K Buy
+4,185
New +$663K 0.06% 242
2019
Q2
– Sell
-944
Closed -$124K – 381
2019
Q1
$124K Hold
944
– – 0.02% 356
2018
Q4
$396K Buy
+944
New +$126K 0.1% 138

Other funds holding LH

Symmetry Partners's LH Position: Q3 2024 in Review

Symmetry Partners sold out of Labcorp (LH) in Q3 2024, closing a stake of 1,581 shares — an estimated $322K sold.

Symmetry Partners first reported a position in LH in Q4 2018 and held it in 18 quarters. The position peaked at $845K in Q4 2021. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.

  • Symmetry Partners reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 1,581 Labcorp shares in Q3 2024, an estimated $322K.
  • Symmetry Partners first reported a position in Labcorp in Q4 2018 and held it in 18 quarters.
  • Symmetry Partners's Labcorp position peaked at $845K in Q4 2021.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.